Table of Contents

May 1, 2023; Volume 64,Issue 5

  1. Ahmadzadehfar, Hojjat

    1. Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?
      Benedikt Feuerecker, Clemens Kratochwil, Hojjat Ahmadzadehfar, Alfred Morgenstern, Matthias Eiber, Ken Herrmann and Kelsey L. Pomykala
      Journal of Nuclear Medicine May 1, 2023, 64 (5) 685-692; DOI: https://doi.org/10.2967/jnumed.122.265353

  2. Aigner, Clemens

    1. Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
      Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
      Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Marc Ingenwerth, Lukas Kessler, Kim M. Pabst, Francesco Barbato, Katharina Lueckerath, Stefan Kasper, Michael Nader, Hans-Ulrich Schildhaus, Claudia Kesch, Bastian von Tresckow, Christine Hanoun, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kümmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Marco Niedergethmann, Boris Hadaschik, Viktor Grünwald, Jens T. Siveke, Ken Herrmann and Wolfgang P. Fendler
      Journal of Nuclear Medicine May 1, 2023, 64 (5) 711-716; DOI: https://doi.org/10.2967/jnumed.122.264689

  3. Aparici, Carina Mari

    1. A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
      A Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
      Heying Duan, Pejman Ghanouni, Bruce Daniel, Jarrett Rosenberg, Alan Thong, Christian Kunder, Carina Mari Aparici, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru
      Journal of Nuclear Medicine May 1, 2023, 64 (5) 744-750; DOI: https://doi.org/10.2967/jnumed.122.264448

  4. Aslani, Alireza

    1. <sup>64</sup>Cu Treatment Planning and <sup>67</sup>Cu Therapy with Radiolabeled [<sup>64</sup>Cu/<sup>67</sup>Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
      64Cu Treatment Planning and 67Cu Therapy with Radiolabeled [64Cu/67Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
      Dale L. Bailey, Kathy P. Willowson, Matthew Harris, Colin Biggin, Alireza Aslani, Nigel A. Lengkeek, Jon Stoner, M. Enid Eslick, Harry Marquis, Michelle Parker, Paul J. Roach and Geoffrey P. Schembri
      Journal of Nuclear Medicine May 1, 2023, 64 (5) 704-710; DOI: https://doi.org/10.2967/jnumed.122.264586

  5. Asmus, Inga

    1. Initial Results of <sup>68</sup>Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
      Initial Results of 68Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
      Philipp Backhaus, Matthias C. Burg, Inga Asmus, Michaela Pixberg, Florian Büther, Hans-Jörg Breyholz, Randy Yeh, Stefanie B. Weigel, Patricia Stichling, Walter Heindel, Stefanie Bobe, Peter Barth, Joke Tio and Michael Schäfers
      Journal of Nuclear Medicine May 1, 2023, 64 (5) 717-723; DOI: https://doi.org/10.2967/jnumed.122.264871

  6. Awad, Robin Maximilian

    1. Targeted α-Therapy Using <sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment
      Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment
      Thomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, Janik Puttemans, Yana Dekempeneer, Kevin De Jonghe, Wout de Mey, Quentin Lecocq, Yannick De Vlaeminck, Robin Maximilian Awad, Cleo Goyvaerts, Kim De Veirman, Alfred Morgenstern, Frank Bruchertseifer, Marleen Keyaerts, Nick Devoogdt, Matthias D’Huyvetter and Karine Breckpot
      Journal of Nuclear Medicine May 1, 2023, 64 (5) 751-758; DOI: https://doi.org/10.2967/jnumed.122.264752

  7. Backhaus, Philipp

    1. Initial Results of <sup>68</sup>Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
      Initial Results of 68Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
      Philipp Backhaus, Matthias C. Burg, Inga Asmus, Michaela Pixberg, Florian Büther, Hans-Jörg Breyholz, Randy Yeh, Stefanie B. Weigel, Patricia Stichling, Walter Heindel, Stefanie Bobe, Peter Barth, Joke Tio and Michael Schäfers
      Journal of Nuclear Medicine May 1, 2023, 64 (5) 717-723; DOI: https://doi.org/10.2967/jnumed.122.264871

  8. Bailey, Dale L.

    1. <sup>64</sup>Cu Treatment Planning and <sup>67</sup>Cu Therapy with Radiolabeled [<sup>64</sup>Cu/<sup>67</sup>Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
      64Cu Treatment Planning and 67Cu Therapy with Radiolabeled [64Cu/67Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry
      Dale L. Bailey, Kathy P. Willowson, Matthew Harris, Colin Biggin, Alireza Aslani, Nigel A. Lengkeek, Jon Stoner, M. Enid Eslick, Harry Marquis, Michelle Parker, Paul J. Roach and Geoffrey P. Schembri
      Journal of Nuclear Medicine May 1, 2023, 64 (5) 704-710; DOI: https://doi.org/10.2967/jnumed.122.264586

  9. Barbato, Francesco

    1. Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
      Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
      Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Marc Ingenwerth, Lukas Kessler, Kim M. Pabst, Francesco Barbato, Katharina Lueckerath, Stefan Kasper, Michael Nader, Hans-Ulrich Schildhaus, Claudia Kesch, Bastian von Tresckow, Christine Hanoun, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kümmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Marco Niedergethmann, Boris Hadaschik, Viktor Grünwald, Jens T. Siveke, Ken Herrmann and Wolfgang P. Fendler
      Journal of Nuclear Medicine May 1, 2023, 64 (5) 711-716; DOI: https://doi.org/10.2967/jnumed.122.264689
    2. Unspecific <sup>18</sup>F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
      Unspecific 18F-PSMA-1007 Bone Uptake Evaluated Through PSMA-11 PET, Bone Scanning, and MRI Triple Validation in Patients with Biochemical Recurrence of Prostate Cancer
      Robert Seifert, Tugce Telli, Marcel Opitz, Francesco Barbato, Christoph Berliner, Michael Nader, Lale Umutlu, Martin Stuschke, Boris Hadaschik, Ken Herrmann and Wolfgang P. Fendler
      Journal of Nuclear Medicine May 1, 2023, 64 (5) 738-743; DOI: https://doi.org/10.2967/jnumed.118.215434

  10. Bartenstein, Peter

    1. Toward Single-Time-Point Image-Based Dosimetry of <sup>177</sup>Lu-PSMA-617 Therapy
      Open Access
      Toward Single-Time-Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy
      Julia Brosch-Lenz, Astrid Delker, Friederike Völter, Lena M. Unterrainer, Lena Kaiser, Peter Bartenstein, Sibylle Ziegler, Arman Rahmim, Carlos Uribe and Guido Böning
      Journal of Nuclear Medicine May 1, 2023, 64 (5) 767-774; DOI: https://doi.org/10.2967/jnumed.122.264594
« Previous (Pages : 1 2 3 4 5 6 ... 22) Next »
Back to top

In this issue